ECU
LLY icon

Egerton Capital (UK)’s Eli Lilly LLY Stock Holding History

Egerton Capital (UK)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-492,808
Closed -$407M – 30
2025
Q1 		$407M Buy
492,808
+211,827
+75% +$176M 4.7% 9
2024
Q4 		$217M Buy
+280,981
New +$233M 2.51% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Egerton Capital (UK)'s LLY Position: Q2 2025 in Review

Egerton Capital (UK) sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 492,808 shares — an estimated $407M sold.

Egerton Capital (UK) first reported a position in LLY in Q4 2024 and held it in 2 quarters. The position peaked at $407M in Q1 2025. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Egerton Capital (UK) reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Egerton Capital (UK) sold 492,808 Eli Lilly shares in Q2 2025, an estimated $407M.
  • Egerton Capital (UK) first reported a position in Eli Lilly in Q4 2024 and held it in 2 quarters.
  • Egerton Capital (UK)'s Eli Lilly position peaked at $407M in Q1 2025.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Egerton Capital (UK)'s 13F filing for Q2 2025, filed 12 Aug 2025.